Hisashi Narahara Selected Research

Hisashi Narahara Research Topics

Disease

30	Neoplasms (Cancer) 01/2021 - 02/2006
27	Endometriosis 12/2021 - 10/2004
17	Ovarian Neoplasms (Ovarian Cancer) 03/2018 - 01/2006
16	Cysts 12/2021 - 09/2004
16	Endometrial Neoplasms (Endometrial Cancer) 01/2014 - 11/2005
6	Carcinogenesis 01/2019 - 01/2007
6	Choriocarcinoma 10/2012 - 01/2008
5	Fibrosis (Cirrhosis) 12/2019 - 04/2007
4	Carcinoma (Carcinomatosis) 03/2021 - 06/2009
4	Pathologic Processes 08/2007 - 04/2006
3	Leiomyoma (Uterine Fibroids) 01/2020 - 02/2009
3	Hypoxia (Hypoxemia) 01/2019 - 04/2006
3	Bacterial Infections (Bacterial Infection) 01/2017 - 08/2006
3	Leukemia 11/2016 - 07/2007
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2016 - 07/2007
3	Vomiting 03/2016 - 12/2013
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2015 - 06/2009
3	Ovarian Epithelial Carcinoma 03/2014 - 01/2010
2	Small Cell Carcinoma 01/2019 - 03/2011
2	Infections 01/2018 - 01/2010
2	Cicatrix (Scar) 09/2015 - 05/2013
2	Ectopic Pregnancy 01/2015 - 08/2008
2	Tubal Pregnancy 01/2015 - 08/2008
2	Neoplasm Metastasis (Metastasis) 04/2012 - 06/2009
2	Myoma 02/2009 - 10/2004
1	Abscess 01/2020
1	Pain (Aches) 01/2020
1	Chromosomal Instability (Chromosome Stability) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Disease Progression 01/2020
1	Neutropenia 01/2020
1	Uterine Neoplasms (Uterine Cancer) 01/2020
1	Skin Diseases (Skin Disease) 12/2019
1	Uterine Didelphys 04/2018
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 04/2018

Drug/Important Bio-Agent (IBA)

17	Histone Deacetylase InhibitorsIBA 03/2018 - 01/2006
11	thiazolyl blueIBA 05/2010 - 01/2006
9	Histone Deacetylases (Histone Deacetylase)IBA 03/2018 - 01/2006
8	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2008
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 09/2004
7	Histones (Histone)IBA 01/2014 - 01/2010
5	MicroRNAs (MicroRNA)IBA 12/2021 - 03/2013
5	Estrogens (Estrogen)FDA Link 01/2017 - 11/2005
5	Biological ProductsIBA 01/2012 - 01/2010
5	Therapeutic UsesIBA 01/2012 - 01/2010
4	bufalinIBA 01/2012 - 11/2005
3	ChemokinesIBA 01/2020 - 10/2004
3	CollagenIBA 01/2020 - 04/2007
3	LigandsIBA 01/2019 - 10/2012
3	Phosphotransferases (Kinase)IBA 07/2017 - 05/2009
3	Messenger RNA (mRNA)IBA 01/2017 - 03/2013
3	Cisplatin (Platino)FDA LinkGeneric 03/2011 - 01/2010
3	ChromatinIBA 01/2011 - 01/2010
3	Pharmaceutical PreparationsIBA 11/2010 - 01/2006
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2010 - 06/2009
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2021 - 04/2012
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2020 - 01/2017
2	Cyclin D1IBA 07/2017 - 11/2016
2	A-Form DNA (A-DNA)IBA 01/2017 - 03/2008
2	Aromatase InhibitorsIBA 10/2016 - 02/2009
2	Hormones (Hormone)IBA 10/2014 - 07/2009
2	Death Domain ReceptorsIBA 01/2014 - 12/2013
2	Homeobox A10 ProteinsIBA 01/2014 - 07/2011
2	Cadherins (E-Cadherin)IBA 01/2014 - 07/2011
2	Valproic Acid (Depakote)FDA LinkGeneric 09/2013 - 01/2007
2	Proteins (Proteins, Gene)FDA Link 10/2012 - 01/2011
2	PK 11195 (PK11195)IBA 10/2012 - 01/2010
2	KN 93IBA 08/2012 - 05/2009
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 08/2012 - 05/2009
2	CalciumIBA 08/2012 - 05/2009
2	MethyltransferasesIBA 07/2011 - 03/2008
2	LipidsIBA 06/2011 - 11/2008
2	Ether (Diethyl Ether)IBA 06/2011 - 11/2008
2	Phospholipids (Phosphatides)FDA LinkGeneric 06/2011 - 11/2008
2	erucylphosphocholineIBA 06/2011 - 11/2008
2	InterferonsIBA 01/2011 - 09/2004
2	Bromodeoxyuridine (BrdU)IBA 07/2007 - 11/2005
1	Histone Deacetylase 6IBA 03/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Melanins (Melanin)IBA 10/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2020
1	ICG 001IBA 12/2019
1	CREB-Binding ProteinIBA 12/2019
1	CateninsIBA 12/2019
1	Decitabine FDA Link 01/2019

Therapy/Procedure

18	Therapeutics 01/2021 - 04/2008
12	Aftercare (After-Treatment) 12/2019 - 01/2006
11	Drug Therapy (Chemotherapy) 01/2020 - 01/2008
7	Hysterectomy 01/2019 - 10/2004
4	Radiotherapy 01/2020 - 01/2008
4	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 02/2010
3	Conservative Treatment 09/2015 - 08/2008
2	Uterine Myomectomy 01/2020 - 02/2009
2	Adjuvant Chemotherapy 04/2018 - 05/2014
2	Cesarean Section (Caesarean Section) 09/2015 - 12/2013
2	Salpingectomy 01/2015 - 08/2008
2	Combined Modality Therapy 03/2011 - 06/2009
1	Palliative Care (Palliative Therapy) 01/2020
1	Laparotomy 01/2018
1	Ligation 01/2018